WuXi Biologics to Build State-of-the-Art Biologics Production Facility in Massachusetts

WuXi Biologics and the Worcester Business Development Corporation (WBDC) have announced the successful signing of a land deal for WuXi Biologics’ clinical and commercial manufacturing facility (MFG11) in Worcester at The Reactory, a 46-acre master-planned biomanufacturing campus. The approximately 107,000-square-foot, two-story facility will be operational in 2022 and create 150 new jobs. Craig Blais, the president and CEO of the WBDC, stated, “WuXi Biologics’ decision to locate its first US biomanufacturing facility in Worcester at The Reactory confirms the value of Worcester’s strong life sciences ecosystem. We expect other biotech manufacturers will soon follow their lead.” Learn More